SCHEMBL5819043

SCHEMBL5819043

Fc1ccccc1-c1ncsc1-c1ccnc(NC2CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 7/20 0.43
▸ MAPK9 P45984 7/20 0.43
▸ MAPK10 P53779 5/20 0.43
▸ CDK4 P11802 8/20 0.42
▸ GSK3B P49841 5/20 0.42
▸ CDK2 P24941 5/20 0.42
▸ RET P07949 4/20 0.40
▸ CDK1 P06493 4/20 0.40
▸ CCNB1 P14635 4/20 0.40
▸ MAPK13 O15264 2/20 0.40
▸ MAPKAPK2 P49137 2/20 0.40
▸ MAPK12 P53778 2/20 0.40
▸ CDC7 O00311 2/20 0.40
▸ JAK2 O60674 2/20 0.40
▸ CCNB2 O95067 2/20 0.40
▸ MAP4K4 O95819 2/20 0.40
▸ INSR P06213 2/20 0.40
▸ CSF1R P07333 2/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ PRKACA P17612 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819164 0.95 CDK1 (0.46) MAPK8MAPK9MAPK10CDK4GSK3B
SCHEMBL5819153 0.81 MAPK14 (0.50) MAPK8MAPK9CDK4GSK3BCDK2
SCHEMBL5813505 0.80 BRAF (0.52) MAPK8MAPK9MAPK10CDK4GSK3B
SCHEMBL5813694 0.77 KCNH2 (0.45) MAPK8MAPK9MAPK10CDK4GSK3B
SCHEMBL5816273 0.77 KCNH2 (0.53) —
SCHEMBL5819338 0.77 MAPK13 (0.48) MAPK8MAPK9MAPK10CDK4GSK3B
SCHEMBL5819869 0.77 MAPK13 (0.45) MAPK8MAPK9GSK3BMAPK13MAPKAPK2
SCHEMBL5819159 0.76 MAPK13 (0.48) MAPK8MAPK9MAPK10CDK4GSK3B
SCHEMBL5816324 0.76 BRAF (0.49) MAPK10CDK4GSK3BCDK2RET
SCHEMBL5818808 0.76 KCNH2 (0.50) MAPK8MAPK9MAPK10CDK4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 — — WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 — — WO disclosed
Send feedback